ITDS

In radiological tests, breast abnormalities are categorized from BIRADS-1 to BIRADS-5 based on the likelihood of cancer. Abnormalities identified as BIRADS-3 require follow-up every 3 to 6 months, while those diagnosed as BIRADS-4a and higher require a biopsy. The limitations of Sonography in detecting these abnormalities often result in delays in patient treatment and necessary biopsies. The Impedimetric Tumor Detection System (ITDS) device is a new and innovative technology where a specially designed probe is inserted into the patient’s body under ultrasound guidance and removed after a few seconds, with the test results instantly displayed. ITDS can be particularly beneficial for young patients with dense breast tissue, especially those with BI-RADS3 masses that are difficult to evaluate with mammography. Additionally, patients with BI-RADS3 masses and a family history of breast cancer can also benefit from this system. This device also has important applications in distinguishing simple fibroadenomas from complex fibroadenomas and phyllodes tumors.